Gut dysbiosis associated with clinical prognosis of patients with primary biliary cholangitis
Masanori Furukawa(Nara Medical University), Hitoshi Yoshiji(Nara Medical University), Yasuhito Tanaka(Kumamoto University), Soichiro Saikawa(Nara Medical University), Yasuhiko Sawada(Nara Medical University), Junichi Yamao(Nara Medical University), Koh Kitagawa(Nara Medical University), Tadashi Namisaki(Nara Medical University), Akitoshi Douhara(Nara Medical University), Mitsuteru Kitade(Nara Medical University), Hiroaki Takaya(Nara Medical University), Hideto Kawaratani(Nara Medical University), Akira Mitoro(Nara Medical University), Takemi Akahane(The Japanese Society of Gastroenterological Surgery), Kosuke Kaji(Nara Medical University), Takako Inoue(Kaneka (United States)), Kei Moriya(Nara Medical University), Shinya Sato(Kyushu University), Jiro Nakayama(Kyushu University), Naotaka Shimozato(Nara Medical University), Rie Momoda(Kyushu University)
Cited by 87
Related Papers
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
|Journal of Gastroenterology|2021|424
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
|Journal of Gastroenterology|2018|242
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241
Evidence‐based clinical practice guidelines for liver cirrhosis 2020
|Hepatology Research|2021|202